Eva Cernuda Morollón-rekin lankidetzan egindako argitalpenak (7)

2020

  1. No association between migraine frequency, white matter lesions and silent brain infarctions: a study in a series of women with chronic migraine

    European Journal of Neurology, Vol. 27, Núm. 8, pp. 1689-1696

2015

  1. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine

    Cephalalgia, Vol. 35, Núm. 4, pp. 310-316

  2. Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?

    Cephalalgia, Vol. 35, Núm. 10, pp. 864-868

  3. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine

    Pain, Vol. 156, Núm. 5, pp. 820-824

2014

  1. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine

    Headache, Vol. 54, Núm. 6, pp. 987-995

  2. Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions

    Journal of the Neurological Sciences, Vol. 336, Núm. 1-2, pp. 180-183

2013

  1. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

    Neurology, Vol. 81, Núm. 14, pp. 1191-1196